Jason Barbour net worth
Quick answer
Jason Barbour's estimated net worth is $720K (range $504K – $1.08M) as of 2026. Jason Barbour is CEO at Synkrino Biotherapeutics. Synkrino Biotherapeutics valuation.
Jason Barbour is CEO at Synkrino Biotherapeutics (YC S18). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Bachelor's degree from the University of California, Berkeley
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 2
- Website: http://www.synkrino.bio
Who is Jason Barbour?
Jason Barbour is a co-founder of Synkrino Biotherapeutics, a company associated with Y Combinator from the summer of 2018.
Highlights:
- University of California, Berkeley
- Y Combinator S18
- Biotechnology entrepreneur
About Synkrino Biotherapeutics
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
FAQ: Jason Barbour net worth and Synkrino Biotherapeutics valuation
What is Jason Barbour's net worth?
Jason Barbour's estimated net worth is $720K (range $504K – $1.08M) as of 2026. Jason Barbour is CEO at Synkrino Biotherapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Synkrino Biotherapeutics valuation?
Synkrino Biotherapeutics's estimated valuation on Entrepreneurial Check is $1.2M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Jason Barbour's role?
Jason Barbour is CEO at Synkrino Biotherapeutics, a Y Combinator-backed startup (batch S18).